Lisa J Herrinton

Summary

Affiliation: Kaiser Permanente
Country: USA

Publications

  1. ncbi Association between anti-TNF-α therapy and all-cause mortality
    Lisa J Herrinton
    Division of Research, Kaiser Permanente, Oakland, CA, USA
    Pharmacoepidemiol Drug Saf 21:1311-20. 2012
  2. ncbi Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010
    Lisa J Herrinton
    Kaiser Permanente Northern California, Oakland, CA, USA
    Gastroenterology 143:382-9. 2012
  3. ncbi Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, 94612, USA
    Am J Gastroenterol 106:2146-53. 2011
  4. ncbi Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
    Pharmacoepidemiol Drug Saf 20:1199-209. 2011
  5. ncbi Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
    Gastroenterology 137:502-11. 2009
  6. ncbi Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project
    Lisa J Herrinton
    Cancer Research Network, Division of Research, Northern California Kaiser Permanente, 2000 Broadway Ave, Oakland, CA 94612, USA
    J Clin Oncol 23:4275-86. 2005
  7. ncbi Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
    Inflamm Bowel Dis 13:451-61. 2007
  8. ncbi Complications at the end of life in ovarian cancer
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
    J Pain Symptom Manage 34:237-43. 2007
  9. ncbi The incidence of hepatosplenic T-cell lymphoma in a large managed care organization, with reference to anti-tumor necrosis factor therapy, Northern California, 2000-2006
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA
    Pharmacoepidemiol Drug Saf 21:49-52. 2012
  10. ncbi Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, 2000 Broadway Avenue, Oakland, CA 94612, USA
    Am J Gastroenterol 103:1998-2006. 2008

Research Grants

  1. Epidemiology of Marginal Zone Lymphoma
    Lisa Herrinton; Fiscal Year: 2003

Detail Information

Publications45

  1. ncbi Association between anti-TNF-α therapy and all-cause mortality
    Lisa J Herrinton
    Division of Research, Kaiser Permanente, Oakland, CA, USA
    Pharmacoepidemiol Drug Saf 21:1311-20. 2012
    ..To compare mortality among patients with selected autoimmune diseases treated with anti-tumor necrosis factor alpha (TNF-α) agents with similar patients treated with non-biologic therapies...
  2. ncbi Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010
    Lisa J Herrinton
    Kaiser Permanente Northern California, Oakland, CA, USA
    Gastroenterology 143:382-9. 2012
    ..The relationship between inflammatory bowel disease (IBD) and the incidence and mortality of colorectal adenocarcinoma (CRC) has not been evaluated recently...
  3. ncbi Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, 94612, USA
    Am J Gastroenterol 106:2146-53. 2011
    ..The objective of this study was to assess inflammatory bowel disease (IBD) medications in relation to lymphoma risk...
  4. ncbi Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
    Pharmacoepidemiol Drug Saf 20:1199-209. 2011
    ..Understanding the absolute and comparative risks of adverse events in patient and disease subpopulations is critical for optimal prescribing of biologics...
  5. ncbi Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
    Gastroenterology 137:502-11. 2009
    ..The management of inflammatory bowel disease (IBD) has become increasingly complicated, and it is unknown whether poor outcomes (prolonged steroid use, hospitalizations, and surgery) have declined in the general population...
  6. ncbi Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project
    Lisa J Herrinton
    Cancer Research Network, Division of Research, Northern California Kaiser Permanente, 2000 Broadway Ave, Oakland, CA 94612, USA
    J Clin Oncol 23:4275-86. 2005
    ..We investigated the efficacy of contralateral prophylactic mastectomy (CPM) in reducing contralateral breast cancer incidence and breast cancer mortality among women who have already been diagnosed with breast cancer...
  7. ncbi Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
    Inflamm Bowel Dis 13:451-61. 2007
    ..There are few contemporary estimates of prevalence rates for inflammatory bowel disease (IBD) in diverse North American communities...
  8. ncbi Complications at the end of life in ovarian cancer
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
    J Pain Symptom Manage 34:237-43. 2007
    ..71, 95% confidence interval=0.53, 0.94, P for trend=0.02). The study, which preceded the establishment of palliative care programs, suggests that care given to ovarian cancer patients at the end of life may be inadequate...
  9. ncbi The incidence of hepatosplenic T-cell lymphoma in a large managed care organization, with reference to anti-tumor necrosis factor therapy, Northern California, 2000-2006
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA
    Pharmacoepidemiol Drug Saf 21:49-52. 2012
    ..To better understand this relationship, we conducted an epidemiologic study in the Kaiser Permanente membership...
  10. ncbi Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, 2000 Broadway Avenue, Oakland, CA 94612, USA
    Am J Gastroenterol 103:1998-2006. 2008
    ..2 million members of Kaiser Permanente, Northern California, for the period 1996-2002...
  11. ncbi Patterns of infliximab use among Crohn's disease patients in a community setting
    Alice R Pressman
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
    Inflamm Bowel Dis 14:1265-72. 2008
    ..We sought to understand predictors of initiation and discontinuation of infliximab in the community-based setting of Kaiser Permanente, Northern California, which provides integrated care to its members...
  12. ncbi Irrigation practices in long-term survivors of colorectal cancer with colostomies
    Marcia Grant
    City of Hope National Medical Center, Beckman Research Institute, Duarte, CA, USA
    Clin J Oncol Nurs 16:514-9. 2012
    ..The article also will explore healthcare professionals' role in ensuring patients and family members are educated and well informed about their options regarding temporary or permanent ostomies...
  13. ncbi Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization
    Xiaoping Weng
    Division of Research, Kaiser Permanente, Oakland, California 94612, USA
    Am J Gastroenterol 102:1429-35. 2007
    ....
  14. ncbi Urine bisphenol-A (BPA) level in relation to semen quality
    De Kun Li
    Division of Research, Kaiser Foundation Research Institute, Kaiser Permanente, Oakland, California, USA
    Fertil Steril 95:625-30.e1-4. 2011
    ..To determine whether urine bisphenol-A (BPA) levels are associated with lower semen quality...
  15. ncbi Association between anti-TNF-α therapy and interstitial lung disease
    Lisa J Herrinton
    Division of Research, Kaiser Permanente, Oakland, CA, USA
    Pharmacoepidemiol Drug Saf 22:394-402. 2013
    ..Anti-tumor necrosis factor-α (TNF-α) agents have been hypothesized to increase the risk of interstitial lung disease (ILD), including its most severe manifestation, pulmonary fibrosis...
  16. ncbi Gastroenterologists' attitudes and self-reported practices regarding inflammatory bowel disease
    Andrea Altschuler
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
    Inflamm Bowel Dis 14:992-9. 2008
    ....
  17. ncbi Gender differences in quality of life among long-term colorectal cancer survivors with ostomies
    Marcia Grant
    City of Hope National Medical Center, Beckman Research Institute, Duarte, CA, USA
    Oncol Nurs Forum 38:587-96. 2011
    ..To describe how gender shapes the concerns and adaptations of long-term (i.e., more than five years) colorectal cancer survivors with ostomies...
  18. ncbi Validity of computerized diagnoses, procedures, and drugs for inflammatory bowel disease in a northern California managed care organization
    Liyan Liu
    Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
    Pharmacoepidemiol Drug Saf 18:1086-93. 2009
    ..Resources for studying inflammatory bowel disease (IBD) are needed in evaluations of drug safety including traditional drugs and new biologics agents. We developed an IBD registry, with ascertainment from computerized visit information...
  19. ncbi Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006
    Oren Abramson
    Division of Pediatric Gastroenterology, Kaiser Permanente Northern California, Santa Clara, CA 95051, USA
    J Pediatr 157:233-239.e1. 2010
    ..To examine the incidence and prevalence of pediatric inflammatory bowel disease (IBD) during 1996-2006 in a community-based health-care delivery system...
  20. ncbi Positive, negative, and disparate--women's differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy
    Andrea Altschuler
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
    Breast J 14:25-32. 2008
    ..This dichotomy could be an important factor to discuss in counseling women considering the procedure...
  21. ncbi Early and late complications among long-term colorectal cancer survivors with ostomy or anastomosis
    Liyan Liu
    Division of Research, Kaiser Permanente, Oakland, California, USA
    Dis Colon Rectum 53:200-12. 2010
    ..Among long-term (>or=5 y) colorectal cancer survivors with permanent ostomy or anastomosis, we compared the incidence of medical and surgical complications and examined the relationship of complications with health-related quality of life...
  22. ncbi Natural history of severe ulcerative colitis in a community-based health plan
    James Allison
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
    Clin Gastroenterol Hepatol 6:999-1003. 2008
    ..We sought to evaluate long-term outcomes of patients with severe ulcerative colitis (UC) after their first hospitalization for the disease...
  23. ncbi Management of cryptorchism and risk of testicular cancer
    Lisa J Herrinton
    Division of Research, Kaiser Permanente, Oakland, CA 94612, USA
    Am J Epidemiol 157:602-5. 2003
    ..In contrast, all four of the early orchiopexies performed on the controls were successful. Boys with failed orchiopexy should be considered for reoperative orchiopexy or orchiectomy to prevent testicular cancer...
  24. ncbi A computerized system to facilitate medical record abstraction in cancer research (United States)
    Ann M Geiger
    Department of Research and Evaluation, Southern California Permanente Medical Group, Pasadena, CA 91188, USA
    Cancer Causes Control 14:469-76. 2003
    ..To implement a computerized system to gather and transmit medical record information from six sites to a centralized database for two cancer prevention studies...
  25. ncbi A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices
    Ann M Geiger
    Research and Evaluation Department, Southern California Permanente Medical Group, 100 S Los Robles, Pasadena, CA 91101, USA
    Arch Intern Med 165:516-20. 2005
    ..We studied the efficacy of bilateral prophylactic mastectomy in women with elevated breast cancer risk cared for in community practices...
  26. ncbi Does the association between serum endostatin, an endogenous anti-angiogenic protein, and acute myocardial infarction differ by race?
    Carlos Iribarren
    Kaiser Permanente Division of Research, 2000 Broadway, 3rd Floor, Oakland, CA 94612, USA
    Vasc Med 11:13-20. 2006
    ..Further research is needed to replicate these findings and to elucidate potential mechanisms for these race/ethnic differences...
  27. ncbi Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department
    Neal H Shorstein
    Department of Ophthalmology Shorstein, Kaiser Permanente, Walnut Creek and Division of Research Herrinton, Kaiser Permanente Northern California, Oakland, California, USA
    J Cataract Refract Surg 39:8-14. 2013
    ..To evaluate post-cataract-surgery endophthalmitis rates in relation to changing practice patterns in antibiotic administration...
  28. ncbi A cohort study of systemic and local complications of toe prostheses
    Gail Husson
    Division of Research, Kaiser Permanente, Oakland, California, USA
    Am J Orthop 32:585-92. 2003
    ..Nonimplant patients were more often diagnosed with derangement of foot or ankle and delayed postoperative healing. We did not find a general association between implants and connective tissue diseases...
  29. ncbi Relationship between urine bisphenol-A level and declining male sexual function
    De Kun Li
    Division of Research, Kaiser Foundation Research Institute, Kaiser Permanente, 2000 Broadway, Oakland, CA 94612, USA
    J Androl 31:500-6. 2010
    ..This finding may enhance the understanding of the BPA effect in human populations, and may have important public health implications given the widespread human exposure to BPA...
  30. ncbi Regarding: a cohort study of systemic and local complications following implantation of testicular prostheses
    Lisa J Herrinton
    Division of Research, Kaiser Permanente, Oakland, CA, USA
    Ann Epidemiol 13:73-7. 2003
  31. ncbi Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy
    Ann M Geiger
    Research and Evaluation Department, Kaiser Permanente Southern California, Pasadena, USA
    J Clin Oncol 24:1350-6. 2006
    ..To understand psychosocial outcomes after prophylactic removal of the contralateral breast in women with unilateral breast cancer...
  32. ncbi What women wish they knew before prophylactic mastectomy
    Sharon J Rolnick
    HealthPartners Research Foundation, Minneapolis, MN 55440 1524, USA
    Cancer Nurs 30:285-91; quiz 292-3. 2007
    ..Clinicians and health educators should be aware of patient needs and must counsel women accordingly...
  33. ncbi Cluster randomized trials: opportunities and barriers identified by leaders of eight health plans
    Kathleen M Mazor
    Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Clinic Foundation, and Fallon Community Health Plan, Worcester, Massachusetts, USA
    Med Care 45:S29-37. 2007
    ....
  34. ncbi The health-related quality of life in long-term colorectal cancer survivors study: objectives, methods and patient sample
    M Jane Mohler
    Southern Arizona Veterans Affairs Health Care System, Tucson, AZ, USA
    Curr Med Res Opin 24:2059-70. 2008
    ..In addition, details are provided regarding the study sample and the psychometric properties of the quantitative data collection measures used. Subsequent manuscripts will present the study findings...
  35. ncbi Efficacy of breast cancer screening in the community according to risk level
    Joann G Elmore
    School of Medicine, Harborview Medical Center, University of Washington, Seattle, WA, USA
    J Natl Cancer Inst 97:1035-43. 2005
    ..The efficacy of breast cancer screening in the community may differ from that suggested by the results of randomized trials, and no data have been available on efficacy among women who have different levels of breast cancer risk...
  36. ncbi Variations in hospice use among cancer patients
    Nancy L Keating
    Division of General Internal Medicine, Brigham and Women s Hospital, Boston, MA, USA
    J Natl Cancer Inst 98:1053-9. 2006
    ....
  37. ncbi Quality of life after bilateral prophylactic mastectomy
    Ann M Geiger
    Research and Evaluation Department, Kaiser Permanente Southern California, Pasadena, California 91188, USA
    Ann Surg Oncol 14:686-94. 2007
    ..Bilateral prophylactic mastectomy in women with increased breast cancer risk dramatically reduces breast cancer occurrence but little is known about psychosocial outcomes...
  38. ncbi Diffusion of aromatase inhibitors for breast cancer therapy between 1996 and 2003 in the Cancer Research Network
    Erin J Aiello
    Group Health Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Breast Cancer Res Treat 107:397-403. 2008
    ..We evaluated diffusion of aromatase inhibitor dispensings for breast cancer treatment in integrated healthcare delivery systems across the United States...
  39. ncbi Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence
    Christina A Clarke
    J Clin Oncol 24:e49-50. 2006
  40. ncbi Social support among women who died of ovarian cancer
    Jody M Jackson
    HealthPartners Research Foundation, Minneapolis, MN 55440 1524, USA
    Support Care Cancer 15:547-56. 2007
    ..We investigated the effects of social support in the last 6 months of life for women who died of ovarian cancer...
  41. ncbi Pain management in the last six months of life among women who died of ovarian cancer
    Sharon J Rolnick
    HealthPartners Research Foundation, Minneapolis, Minnesota 55440, USA
    J Pain Symptom Manage 33:24-31. 2007
    ..Our finding that only 54% of women with pain were given high intensity medication near death indicates room for improvement in the care of ovarian cancer patients at the end of life...
  42. ncbi Specificity of clinical breast examination in community practice
    Joshua J Fenton
    Department of Family and Community Medicine, University of California, Davis, Sacramento, CA 95817, USA
    J Gen Intern Med 22:332-7. 2007
    ....
  43. ncbi Quality of diabetes care among cancer survivors with diabetes
    Nancy L Keating
    Division of General Internal Medicine, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Med Care 45:869-75. 2007
    ..Among patients with chronic medical conditions, unrelated conditions are often undertreated...
  44. ncbi Mortality by medication use among patients with inflammatory bowel disease, 1996-2003
    Susan M Hutfless
    Epidemiology Department, Harvard School of Public Health, Boston, Massachusetts, USA
    Gastroenterology 133:1779-86. 2007
    ..We evaluated mortality by IBD medication use among members of the Kaiser Permanente Northern California IBD Registry...
  45. ncbi Training, quality assurance, and assessment of medical record abstraction in a multisite study
    Lisa M Reisch
    Harborview Medical Center, University of Washington School of Medicine, Seattle, WA 98104-2499, USA
    Am J Epidemiol 157:546-51. 2003
    ..Additionally, a masking study with a subsample of subjects may be a feasible and cost-effective alternative to the time- and cost-intensive methodological approach of masking all medical records...

Research Grants1

  1. Epidemiology of Marginal Zone Lymphoma
    Lisa Herrinton; Fiscal Year: 2003
    ..abstract_text> ..